TDP1 and breast cancer: Wang et al. [47] found that overexpression of MIR-211 can act on the TDP1 target in breast cancer cells, thereby inhibiting its expression, further inhibiting DDR, and reversing the resistance of breast cancer to neoadjuvant chemotherapy drugs.